Analysen zu Novo Nordisk
| 17.06.25 | Novo Nordisk Buy | UBS AG | |
| 16.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.06.25 | Novo Nordisk Buy | UBS AG | |
| 12.06.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 09.06.25 | Novo Nordisk Buy | UBS AG | |
| 06.06.25 | Novo Nordisk Buy | UBS AG | |
| 06.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 02.06.25 | Novo Nordisk Buy | UBS AG | |
| 02.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.05.25 | Novo Nordisk Buy | UBS AG | |
| 19.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.05.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 09.05.25 | Novo Nordisk Buy | UBS AG | |
| 08.05.25 | Novo Nordisk Halten | DZ BANK | |
| 08.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.05.25 | Novo Nordisk Buy | UBS AG | |
| 07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.05.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 02.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | Novo Nordisk Buy | UBS AG | |
| 03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 31.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 19.02.26 | AIR France-KLM Market-Perform | Bernstein Research | |
| 19.02.26 | KRONES Buy | Warburg Research | |
| 19.02.26 | Nestlé Market-Perform | Bernstein Research | |
| 19.02.26 | Airbus Outperform | Bernstein Research | |
| 19.02.26 | Knorr-Bremse Hold | Warburg Research | |
| 19.02.26 | Airbus Overweight | Barclays Capital | |
| 19.02.26 | Nestlé Sector Perform | RBC Capital Markets | |
| 19.02.26 | Renault Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | Airbus Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.26 | Knorr-Bremse Neutral | JP Morgan Chase & Co. | |
| 19.02.26 | Airbus Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | Airbus Hold | Jefferies & Company Inc. | |
| 19.02.26 | Nutrien Equal Weight | Barclays Capital | |
| 19.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 19.02.26 | BAT Overweight | Barclays Capital | |
| 19.02.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 19.02.26 | Enel Overweight | Barclays Capital | |
| 19.02.26 | Airbus Outperform | RBC Capital Markets | |
| 19.02.26 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 19.02.26 | Ahold Delhaize Equal Weight | Barclays Capital | |
| 19.02.26 | London Stock Exchange Overweight | Barclays Capital | |
| 19.02.26 | SAF-HOLLAND Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.26 | PVA TePla Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.26 | Enel Market-Perform | Bernstein Research | |
| 19.02.26 | RATIONAL Outperform | Bernstein Research | |
| 19.02.26 | DWS Group Buy | UBS AG | |
| 19.02.26 | Siemens Energy Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | Bayer Overweight | Barclays Capital | |
| 19.02.26 | Nutrien Outperform | RBC Capital Markets | |
| 19.02.26 | QIAGEN Buy | Jefferies & Company Inc. | |
| 19.02.26 | Heidelberg Materials Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | Mercedes-Benz Group Sector Perform | RBC Capital Markets | |
| 19.02.26 | RELX Overweight | JP Morgan Chase & Co. | |
| 18.02.26 | Enel Buy | Jefferies & Company Inc. | |
| 18.02.26 | NVIDIA Outperform | RBC Capital Markets | |
| 18.02.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 18.02.26 | Dürr Kaufen | DZ BANK | |
| 18.02.26 | NVIDIA Outperform | RBC Capital Markets | |
| 18.02.26 | Netflix Outperform | Bernstein Research | |
| 18.02.26 | Linde Outperform | Bernstein Research | |
| 18.02.26 | UNIQA Insurance kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.02.26 | Glencore Overweight | Barclays Capital | |
| 18.02.26 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 18.02.26 | Bayer Verkaufen | DZ BANK | |
| 18.02.26 | JENOPTIK Neutral | UBS AG | |
| 18.02.26 | UNIQA Insurance kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.02.26 | Unilever Sell | UBS AG | |
| 18.02.26 | Befesa Buy | UBS AG | |
| 18.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 18.02.26 | Dürr Hold | Deutsche Bank AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.